Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
celecoxib (celebrex) (1 trial)
gemcitabine (gemzar) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
Mesothelioma (Phase 3)
Trials (1 total)
Trial APIs (3 total)